(A) Strategy for generating the BAC transgenic line expressing human MrgprX1 driven by mouse MrgprC11promoter. The Mrgprc11 MrgprX1 transgenic mice were mated with Mrgpra3GFP-Cretransgenic mice and then crossed into the Mrgpr-cluster Δ−/−background. Since Mrgpra3 is a subpopulation of Mrgprc11, the GFP-cre will label a subset of MrgprX1 neurons. The purple circle indicates all DRG neurons that lacked the 12 endogenous mouse Mrgprs. The red circle indicates a subpopulation of all MrgprX1 neurons. The green circle indicates the neurons that expressed both MrgprX1 and Cre-GFP. The lower-right picture shows the MrgprX1 DRG neurons that expressed Cre-GFP in the nuclei. (B) The estimated sizes of MrgprX1 cells. The average diameter is 14.7 ± 0.11 μm (n=148). (C) A sample current-clamp recording of MrgprX1 neurons at different concentrations of BAM8-22 (n=3). (D) A sample recording of MrgprX1 neurons in the presence of 100nM for one minute (n=18). (E) A sample recording from Cre-GFP labeled, Mrgpr-cluster Δ −/−(MrgprX1−/−) DRG neurons in the presence of 100nM BAM8-22 (n=7). (F) Pretreatment with cholera toxin (2μg/mL) overnight had no effects on BAM8-22 evoked action potentials (n=5). (G) Pertussis toxin pretreatment (2μg/mL, overnight) completely block BAM8-22 evoked excitability (n=5). (H) Pretreatment with U73122 for 5 minutes greatly reduced, but did not prevent, BAM8-22 mediated excitability (n=8). (I) A Gβγ subunit inhibitor, Gallein (100μM), completely blocked BAM8-22 induced action potential discharges (n=8). (J) Summarized data for total action potentials discharges induced by 100nM BAM8-22 under different conditions. Data were presented as mean ± s.e.m., **** p=0.0001, by two-tailed t test.